MAPPING INTERLEUKIN ENHANCER-BINDING FACTOR-2 GENE (ILF2) TO HUMAN-CHROMOSOME-1 (1Q11-QTER AND 1P11-P12) BY POLYMERASE CHAIN-REACTION AMPLIFICATION OF HUMAN RODENT SOMATIC-CELL HYBRID DNA TEMPLATES
P. Marcoulatos et al., MAPPING INTERLEUKIN ENHANCER-BINDING FACTOR-2 GENE (ILF2) TO HUMAN-CHROMOSOME-1 (1Q11-QTER AND 1P11-P12) BY POLYMERASE CHAIN-REACTION AMPLIFICATION OF HUMAN RODENT SOMATIC-CELL HYBRID DNA TEMPLATES, Journal of interferon & cytokine research, 16(12), 1996, pp. 1035-1038
Interleukin-2 (IL-2) is the first lymphokine secreted following T cell
activation, Several transcription factors regulate IL-2 gene expressi
on, including the nuclear factor of activated T cells (NFAT), NFAT act
s at the antigen receptor response element-2 (ARRE-2) sequence in the
IL-2 enhancer and is the nuclear target of T cell stimulation signals
and the immunosuppressant drugs cyclosporine and FK506, which are pote
nt inhibitors of IL-2 gene transcription, NFAT has been cloned and fou
nd to consist of two subunits, NF45 (ILF2) and NF90 (ILF3), This commu
nication reports the assignment of NF45, interleukin enhancer binding
factor 2 gene (ILF2), to human chromosome 1 (1q11-qter and 1p11-p12) b
y polymerase chain reaction (PCR) amplification of ILF2-specific DNA s
equences from well-characterized human-rodent somatic cell hybrid DNA.